MD Anderson surgeons have found a way to reduce pain and opioid use for lung cancer patients undergoing a lung resection. A recent study led by David Rice, M.B. BCh, professor of Thoracic and Cardiovascular Surgery, and published in the Annals of Surgery, showed that using an Enhanced Recovery After Surgery (ERAS) pathway employing a long-acting local anesthetic (liposomal bupivacaine)...
Surveying the landscape of T cell presence and activity across the lungs of patients treated for localized non-small cell lung cancer, researchers...
An immunotherapy used against advanced non-small cell lung cancer is being tested at MD Anderson for a different...
November is Lung Cancer Awareness Month, and the third Thursday of each November is designated by the American Cancer Society as the Great American Smokeout – a day focused on encouraging Americans to quit smoking.
Tobacco cessation and prevention have long been an area of focus and expertise for MD Anderson, and has been a critical component of the Lung Cancer Moon Shot® since its inception. The effort is part of MD Anderson’s...
The recent outbreak of lung injury and death associated with e-cigarettes and vaping has led to a renewed scrutiny of electronic nicotine...
Building upon the foundational discovery that the targeted therapy poziotinib is a potent and selective inhibitor of specific EGFR and HER2...
Repurposing FDA-approved therapies is a cost-effective way to bring new treatments to patients in need, but identifying those drugs with benefits...
Small precancerous growths in the lungs are capable of progressing to invasive lung cancer, but so little has been known about them that understanding...
Just as a driver’s night vision improves by simply cleaning the headlights, scientists at The University of Texas MD Anderson Cancer Center...
MD Anderson researchers will present clinical trial results of promising combination therapies for a variety of cancers at the 2019 American...